FDA Proposes to Indefinitely Delay Obama Administration Amendments to FDA Regulations on Intended Use
E-mail Disclaimer
We welcome your interest in AGG. However, we cannot represent you nor can we treat unsolicited information as confidential until we know that doing so will not create a conflict of interest. Accordingly, please DO NOT send information about any matter unless you have a written engagement letter from us stating that we represent you as a client.